TIAM1 and prostate carcinoma: More specifically, the mean DFS time of patients with strong Tiam1 overexpression (⩾3.5-fold) in prostate carcinomas was 98 months (95% confidence interval (CI)=77–119), whereas the mean DFS time of patients with weak Tiam1 overexpression (<3.5-fold) was 136 months (95% CI=118–154).